Pharmacokinetics of terazosin enantiomers in healthy chinese male subjects

Chirality

Volumn 24, Issue 12, 2012, Pages 1047-1050

  Liu, Man ^a   Zhang, Dan ^a   Yang, Man ^a   Zhao, Ting ^a   Wang, Xiaolin ^a   Zhang, Yanan ^a   Han, Jing ^a   Liu, Huichen ^a  

^a AEROSPACE CENTER HOSPITAL   (China)

Author keywords

determination; enantiomer; HPLC FD; pharmacokinetics; plasma; terazosin

Indexed keywords

TERAZOSIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHIRALITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; ENANTIOMER; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEREOCHEMISTRY; VALIDATION PROCESS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEALTH; HUMANS; MALE; PRAZOSIN; SPECTROMETRY, FLUORESCENCE; STEREOISOMERISM; YOUNG ADULT;

EID: 84870471118     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.22095     Document Type: Article

References (15)

1. Forray C, Bard JA, Wetzel JM, Chiu G, Shapiro E, Tang R, Lepor H, Hartig PR, Weinshank RL, Branchek TA,. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Mol Pharmacol 1994; 45: 703-708.
2. Nakaki T, Nakayama M, Yamamoto S, Kato R,. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 1990; 37: 30-36.
3. Smith P, Rhodes NP, Ke Y, Foster CS,. Influence of the alpha1-adrenergic antagonist, doxazosin, on noradrenaline-induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells. Prostate 1999; 38: 216-227.
4. Ireland LM, Cain JC, Rotert G, Thomas S, Shoghi S, Hancock AA, Kerwin JF Jr., [3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors-comparison with racemic [3H]terazosin and [3H]prazosin. Eur J Pharmacol 1997; 327: 79-86.
5. Hancock AA, Buckner SA, Ireland LM, Knepper SM, Kerwin JF Jr., Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro. J Recept Signal Transduct Res 1995; 15: 863-885.
6. Kyncl JJ, Horrom BW,. R(+)-terazosin. Patent No. WO/1992/000073.
7. Bu Y, Chen D, Zhao C,. Studies on pharmacokinetics and bioequivalence of terazosin hydrochloride tablets. Chin J Pharm Anal 2007; 27: 1361-1363.
8. Chen J, Lu W, Gao K, Shi Z, Jiang X, Rong Z, Chen H,. Studies on the bioequivalence of domestic terazosin tablet in healthy volunteers. Chin Pharm J 2003; 38: 446-448.
9. Cheah PY, Yuen KH, Liong ML,. Improved high-performance liquid chromatographic analysis of terazosin in human plasma. J Chromatogr B 2000; 745: 439-443.
10. Sekhar EC, Rao TR, Sekhar KR, Naidu MU, Shobha JC, Rani PU, Kumar TV, Kumar VP,. Determination of terazosin in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr B 1998; 710: 137-142.
11. Ferretti R, Gallinella B, La Torre F, Zanitti L, Turchetto L, Mosca A, Cirilli R,. Direct high-performance liquid chromatography enantioseparation of terazosin on an immobilised polysaccharide-based chiral stationary phase under polar organic and reversed-phase conditions. J Chromatogr A 2009; 1216: 5385-5390.
12. Liu M, Zhang D, Han J, Liu H,. Enantiomeric separation of terazosin by NP-HPLC. Chin J Pharm 2012; 43: 53-56.
13. Zavitsanos AP, Alebic-Kolbah T,. Enantioselective determination of terazosin in human plasma by normal phase high-performance liquid chromatography-electrospray mass spectrometry. J Chromatogr A 1998; 794: 45-56.
14. Bansal S, DeStefano A,. Key elements of bioanalytical method validation for small molecules. AAPS J 2007; 9: E109-E114.
15. Achari R, Laddu A,. Terazosin: a new alpha adrenoceptor blocking drug. J Clin Pharmacol 1992; 32: 520-523.